FLJ36031 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.307600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.458600E-01
Normal-vs-Stage2
8.767800E-01
Normal-vs-Stage3
8.619400E-01
Normal-vs-Stage4
5.005400E-01
Stage1-vs-Stage2
4.130800E-01
Stage1-vs-Stage3
3.992200E-01
Stage1-vs-Stage4
1.357820E-01
Stage2-vs-Stage3
9.885400E-01
Stage2-vs-Stage4
5.870400E-01
Stage3-vs-Stage4
6.484000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.422600E-01
Normal-vs-AfricanAmerican
7.415400E-01
Normal-vs-Asian
9.841400E-01
Caucasian-vs-AfricanAmerican
6.816200E-01
Caucasian-vs-Asian
9.237400E-01
AfricanAmerican-vs-Asian
7.560200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.682600E-01
Normal-vs-Female
8.194800E-01
Male-vs-Female
2.665800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.036200E-01
Normal-vs-Age(41-60Yrs)
6.393800E-01
Normal-vs-Age(61-80Yrs)
8.338800E-01
Normal-vs-Age(81-100Yrs)
9.460800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.430600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.672400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.279600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.891910E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.431200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.748800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.162000E-01
Normal-vs-Daily Drinker
9.506200E-01
Normal-vs-Weekly Drinker
5.415800E-01
Normal-vs-Occasional Drinker
6.459000E-01
Normal-vs-Social Drinker
8.010600E-01
Non Drinker-vs-Daily Drinker
9.078600E-01
Non Drinker-vs-Weekly Drinker
3.145600E-01
Non Drinker-vs-Occasional Drinker
3.511600E-01
Non Drinker-vs-Social Drinker
5.220800E-01
Daily Drinker-vs-Weekly Drinker
2.585200E-01
Daily Drinker-vs-Occasional Drinker
3.761200E-01
Daily Drinker-vs-Social Drinker
6.276600E-01
Weekly Drinker-vs-Occasional Drinker
6.590500E-02
Weekly Drinker-vs-Social Drinker
1.444050E-01
Occasional Drinker-vs-Social Drinker
6.659000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.797400E-01
Normal-vs-Grade 2
1.087440E-01
Normal-vs-Grade 3
1.635620E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.806200E-02
Grade 1-vs-Grade 3
3.094800E-01
Grade 1-vs-Grade 4
3.797400E-01
Grade 2-vs-Grade 3
1.565390E-01
Grade 2-vs-Grade 4
1.087440E-01
Grade 3-vs-Grade 4
1.635620E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.171800E-01
Normal-vs-NonDiabetic
9.024000E-01
Diabetic-vs-NonDiabetic
5.254400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.935800E-01
Normal-vs-NoPancreatitis
9.443200E-01
Pancreatitis-vs-NoPancreatitis
3.480400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.712200E-01
Normal-vs-N1
8.877800E-01
N0-vs-N1
5.425800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.283600E-01
Normal-vs-TP53-NonMutant
4.066600E-01
TP53-Mutant-vs-TP53-NonMutant
7.258600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
